IL114673A - Pharmaceutical compositions containing protein for oral administration - Google Patents

Pharmaceutical compositions containing protein for oral administration

Info

Publication number
IL114673A
IL114673A IL11467395A IL11467395A IL114673A IL 114673 A IL114673 A IL 114673A IL 11467395 A IL11467395 A IL 11467395A IL 11467395 A IL11467395 A IL 11467395A IL 114673 A IL114673 A IL 114673A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
oral administration
compositions containing
containing protein
protein
Prior art date
Application number
IL11467395A
Other versions
IL114673A0 (en
Inventor
Miriam Kidron
Hanoch Bar-On
Ehud Ziv
Original Assignee
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service
Priority to IL11467395A priority Critical patent/IL114673A/en
Publication of IL114673A0 publication Critical patent/IL114673A0/en
Priority to PCT/IL1996/000055 priority patent/WO1997003688A1/en
Priority to EP96923034A priority patent/EP0839047A1/en
Publication of IL114673A publication Critical patent/IL114673A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11467395A 1995-07-19 1995-07-19 Pharmaceutical compositions containing protein for oral administration IL114673A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL11467395A IL114673A (en) 1995-07-19 1995-07-19 Pharmaceutical compositions containing protein for oral administration
PCT/IL1996/000055 WO1997003688A1 (en) 1995-07-19 1996-07-16 Pharmaceutical compositions containing protein
EP96923034A EP0839047A1 (en) 1995-07-19 1996-07-16 Pharmaceutical compositions containing protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11467395A IL114673A (en) 1995-07-19 1995-07-19 Pharmaceutical compositions containing protein for oral administration

Publications (2)

Publication Number Publication Date
IL114673A0 IL114673A0 (en) 1995-11-27
IL114673A true IL114673A (en) 2000-12-06

Family

ID=11067792

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11467395A IL114673A (en) 1995-07-19 1995-07-19 Pharmaceutical compositions containing protein for oral administration

Country Status (3)

Country Link
EP (1) EP0839047A1 (en)
IL (1) IL114673A (en)
WO (1) WO1997003688A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885567A (en) * 1993-10-22 1999-03-23 University Of Connecticut Treatment of infection in fowl by oral administration of avian interferon proteins
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
US7655618B2 (en) 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7314859B2 (en) 2002-12-27 2008-01-01 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
CN101547702B (en) 2005-09-06 2016-06-22 奥拉姆德医药公司 For oral administration method of protein and compositions
CA3083698A1 (en) 2008-03-26 2009-10-01 Oramed Ltd. Methods and compositions comprising serpin(s) for oral administration of protein
NO2300031T3 (en) 2008-05-05 2018-02-17
MX2011001313A (en) * 2008-08-04 2011-03-04 Merck Sharp & Dohme Oxazole derivatives useful as inhibitors of faah.
US9006433B2 (en) 2010-04-21 2015-04-14 Merck Sharp & Dohme Corp. Substituted pyrimidines
CN108904810A (en) 2012-01-03 2018-11-30 奥拉姆德有限公司 The method and composition for treating diabetes
CN112755002A (en) 2012-02-01 2021-05-07 奥拉姆德有限公司 Compositions containing protease inhibitors, compositions comprising the same, and methods for producing and using the same
JP6250029B2 (en) 2012-03-30 2017-12-20 ジボダン エス エー N-acyl-amino acid derivatives as food flavoring compounds
JP2016505613A (en) 2013-01-03 2016-02-25 オラムド エルティーディー． Methods and compositions for treating NAFLD, fatty liver, and its sequelae

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US5167947A (en) * 1989-10-26 1992-12-01 Southwest Research Institute Enhancement of absorption of radioprotective drugs

Also Published As

Publication number Publication date
IL114673A0 (en) 1995-11-27
EP0839047A1 (en) 1998-05-06
WO1997003688A1 (en) 1997-02-06

Similar Documents

Publication Publication Date Title
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
IL117041A0 (en) Oral pharmaceutical dosage form
PL322579A1 (en) 2-methyl-thiene-benzodiazeoin prparation for oral administration
IL117728A0 (en) Pharmaceutical compositions for transdermal administration
IL118637A0 (en) Oral pharmaceutical compositions of S(+)-ibuprofen
HUP9903407A3 (en) Oral pharmaceutical preparation containing ibandronat
EP0873749A4 (en) Jellied medicinal composition for oral administration
NZ304982A (en) Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
AU7375598A (en) Stable oral pharmaceutical dosage forms
PL314732A1 (en) S(+)-ethodolac preparations for oral administration
AU5157590A (en) Pharmaceutical compositions for oral administration
PL319898A1 (en) Cyclosporines containing compositions for oral administration
IL114673A (en) Pharmaceutical compositions containing protein for oral administration
IL117817A0 (en) N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them
HU9402785D0 (en) Paramycin formulations for oral administration
HU9500618D0 (en) Oral pharmaceutical compositions
EP0953359A4 (en) Pharmaceutical composition for oral administration
ZA964517B (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
AU5347996A (en) Preparation for oral administration
IL117090A (en) Pharmaceutical compositions containing oxazolidinone derivatives
AU3860797A (en) Pharmaceutical formulations for oral administration
HUP0101012A3 (en) Pharmaceutical composition for oral administration
GB9418029D0 (en) Pharmaceutical compositions for oral administration
GB9408369D0 (en) Oral administration of protein drugs

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees